One-Two Punch: Novel Drug Pairing Could Beat Pancreatic Cancer
June 28, 2023
UC San Diego researchers find a combination of drugs outperformed other treatments in human and mouse models of pancreatic cancer; now urge clinical trial
Your search for “New Drugs” returned 1094 results
Stand Up To Cancer Grant Funds UC San Diego Health Research in Pancreatic Cancer
November 20, 2018
A team of University of California San Diego School of Medicine researchers have been awarded a $1 million Stand Up To Cancer (SU2C) grant to test drugs that block signals that play a critical role in driving growth and progression of pancreatic cancer.
Two Novel Biobanks Offer Investigatory Targets for Cocaine and Oxycodone Addiction
April 26, 2021
Researchers have created to novel biobanks of diverse tissues from animals to further explore the biological bases and consequences of addiction to cocaine and oxycodone.
Century-Old Drug Reverses Autism-like Symptoms in Fragile X Mouse Model
January 15, 2015
…previously reported that a drug used for almost a century to treat trypanosomiasis, or sleeping sickness, reversed environmental autism-like symptoms in mice. Now, a new study published in this week’s online issue of Molecular Autism, suggests that a genetic form of autism-like symptoms in mice are also corrected with the…
Parasite Lost
November 27, 2013
…advanced methodologies that pit drug compounds against specific types of malaria parasite cells, an international team of scientists, including researchers at the University of California, San Diego School of Medicine and the Genomics Institute of the Novartis Research Foundation, have identified a potential new weapon and approach for attacking the…
Researchers Discover a New Mechanism Used by Bacteria to Evade Antibiotics
March 7, 2019
UC San Diego researchers have discovered an unexpected mechanism that allows bacteria to defend themselves against antibiotics, a finding that could lead to retooled drugs to treat infectious diseases.
Gene Editing Technique Helps Find Cancer’s Weak Spots
March 20, 2017
…allowing researchers to develop drugs that will selectively kill them. This is called “synthetic lethality” because the drug is only lethal to mutated (synthetic) cells. Researchers at UC San Diego School of Medicine and Jacobs School of Engineering developed a method to search for synthetic-lethal gene combinations. The technique, published…
Phase III Clinical Trial to Evaluate Calcium Channel Blocker for Parkinson’s
September 30, 2014
…trial to evaluate the drug isradipine, a calcium channel blocker often used to treat high blood pressure, as a potential new treatment for Parkinson disease. The goal of the study is to determine whether the drug can slow the progression of the disease by keeping the brain’s dopamine-producing cells healthier…
UC San Diego Campaign Raises Awareness about “Drugged” Driving
November 13, 2018
Drugged driving has joined drunk driving and distracted driving as a leading cause of motor vehicle collisions. As roadway safety remains a pressing public health concern in California, researchers at University of California San Diego School of Medicine and the Qualcomm Institute have received funding to expand a statewide program…
UC San Diego Researcher Gets $4 Million NCI Award to Study Cancer Drug Resistance, Spread
December 7, 2018
David Cheresh, Distinguished Professor at University of California San Diego School of Medicine, received $4.2 million National Cancer Institute Outstanding Investigator Award to continue his research into cancer’s ability to overcome stress, gain drug resistance and metastasize.
